摘要
癌症已经是全球范围内的一个主要健康问题,因此基于当前研究成果更加有效地治疗策略不断地被提出。慢性的、无法检测的炎症被广泛地认为能够引发癌症。先天性的免疫系统作为第一道防线,其中炎症体是必需的以维持炎性因子和抗炎因子间的微妙平衡,以保证产生一个合适的免疫反应且不伤害到宿主。研究已经揭示出一个显著的,但是矛盾的宿主免疫反应和肿瘤发生间的联系。确实,由危险信号激活的多个蛋白复合免疫炎症体在癌症发生和发展过程中似乎起着多种和有时是矛盾的、抑制的或者刺激的作用,并伴有一个显著的环境依赖性。多效性的炎症体可能作用于细胞自治水平并通过炎症突触类型的程序性细胞凋亡来消除恶性细胞,但是相反的,也有可能产生有利于肿瘤细胞生长和它们的微环境营养的因子。此外,依靠天冬氨酸-1激活的炎性体能够引发无菌炎症,并且提供致癌因素,所有抗原提呈细胞能够引出抗肿瘤免疫反应。明确的说,环境特异影响肿瘤发生的炎症体代表了一个新的研究领域,具有潜在作用以进出一个有前景的新颖的靶标用于癌症治疗。
关键词: 癌症,天冬氨酸-1,炎症,炎症体,促炎性细胞因子,细胞死亡。
Current Drug Targets
Title:Inflammasome, Inflammation and Cancer: An Interrelated Pathobiological Triad
Volume: 16 Issue: 3
Author(s): Gyorgyi Muzes and Ferenc Sipos
Affiliation:
关键词: 癌症,天冬氨酸-1,炎症,炎症体,促炎性细胞因子,细胞死亡。
摘要: Cancer represents a major health problem worldwide, therefore on the basis of current research results constantly more effective therapeutic strategies are expected. Chronic, unchecked inflammation has widely been suggested to trigger carcinogenesis. The innate immune system ensures a first line host defense in which the inflammasome is essential maintaining a delicate balance betweeen pro- and anti-inflammatory signals in order to generate an appropriate immune response without harming the host. Studies have revealed a remarkable, but contradictory link of host inflammatory responses to tumorigenesis. Indeed, activation of the multiprotein complex inflammasome by danger signals seems to play diverse and sometimes conflicting, suppressive or stimulatory role in cancer development and progression with a significant context-dependency. The pleitropic inflammasomes may act at cellautonomous level to eliminate malignant cells via the programmed cell death type of inflammatory pyroptosis, but on the contrary, may favor the production of gowth and trophic factors for tumor cells and their microenvironment. Further, upon caspase-1 activation the inflammasome can provoke sterile inflammation, and thus facilitate carcinogenesis, though in antigen-presenting cells it can elicit anti-tumor immune responses. Clarifying the exact, context-specific impact of inflammasomes on tumorigenesis represents a new research area with the potential to introduce promising novel targets for cancer therapeutics.
Export Options
About this article
Cite this article as:
Gyorgyi Muzes and Ferenc Sipos , Inflammasome, Inflammation and Cancer: An Interrelated Pathobiological Triad, Current Drug Targets 2015; 16 (3) . https://dx.doi.org/10.2174/1389450115666141229154157
DOI https://dx.doi.org/10.2174/1389450115666141229154157 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Resveratrol as a Chemopreventive Agent: A Promising Molecule for Fighting Cancer
Current Drug Targets Methionine Aminopeptidases as Potential Targets for Treatment of Gastrointestinal Cancers and other Tumors
Current Drug Targets A Comprehensive Review on Chrysin: Emphasis on Molecular Targets, Pharmacological Actions and Bio-pharmaceutical Aspects
Current Drug Targets Novel Molecular-Targeted Therapeutics for the Treatment of Cancer
Anti-Cancer Agents in Medicinal Chemistry Targeting the RAS Signaling Pathway in Malignant Hematologic Diseases
Current Drug Targets The Holy Grail of Polymer Therapeutics for Cancer Therapy: An Overview on the Pharmacokinetics and Bio Distribution
Current Drug Metabolism Anti-cancer and Other Bioactivities of Korean Angelica gigas Nakai (AGN) and Its Major Pyranocoumarin Compounds
Anti-Cancer Agents in Medicinal Chemistry Tubulin Colchicine Binding Site Inhibitors as Vascular Disrupting Agents in Clinical Developments
Current Medicinal Chemistry HLA-G - From Fetal Tolerance to a Regulatory Molecule in Inflammatory Diseases
Current Immunology Reviews (Discontinued) Hypothyroidism and Endothelial Function: A Marker of Early Atherosclerosis?
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Inhibition of TGF- Signaling for the Treatment of Tumor Metastasis and Fibrotic Diseases
Current Signal Transduction Therapy TGF-β Receptor Signaling Pathways in Angiogenesis; Emerging Targets for Anti-Angiogenesis Therapy
Current Pharmaceutical Biotechnology Activation of LINE-1 Retrotransposon Increases the Risk of Epithelial-Mesenchymal Transition and Metastasis in Epithelial Cancer
Current Molecular Medicine Targeting the Folate Receptor: Improving Efficacy in Inorganic Medicinal Chemistry
Current Medicinal Chemistry Signal Transduction Pathways and Transcriptional Mechanisms as Targets for Prevention of Emergence of Multidrug Resistance in Human Cancer Cells
Current Drug Targets Therapeutic Implications of Superoxide Dismutase And Its Importance in Kinase Drug Discovery
Current Topics in Medicinal Chemistry mTOR Inhibitors: Facing New Challenges Ahead
Current Medicinal Chemistry A Survey on Synthesis Processes of Structured Materials for Biomedical Applications: Iron-based Magnetic Nanoparticles, Polymeric Materials and Polymerization Processes
Current Pharmaceutical Design Butyrate and Colorectal Cancer: The Role of Butyrate Transport
Current Drug Metabolism NK Cell, Monocyte and Non T Cell Biomarkers as Prognostic Indicators in Cancer Immunotherapy
Current Cancer Therapy Reviews